BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 53 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $652,286 | +2.7% | 16,661 | +6.6% | 0.00% | +50.0% |
| Q2 2023 | $635,375 | +97951.7% | 15,634 | +1.0% | 0.00% | -33.3% |
| Q1 2023 | $648 | -13.7% | 15,484 | -10.2% | 0.00% | -25.0% |
| Q4 2022 | $751 | -99.9% | 17,241 | -34.1% | 0.00% | -20.0% |
| Q3 2022 | $1,015,000 | +530.4% | 26,157 | +587.6% | 0.01% | +400.0% |
| Q2 2022 | $161,000 | -3.0% | 3,804 | +4.2% | 0.00% | 0.0% |
| Q1 2022 | $166,000 | -6.2% | 3,652 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $177,000 | +7.3% | 3,666 | +5.8% | 0.00% | 0.0% |
| Q3 2021 | $165,000 | -4.1% | 3,466 | -2.7% | 0.00% | 0.0% |
| Q2 2021 | $172,000 | +14.7% | 3,562 | +9.3% | 0.00% | 0.0% |
| Q1 2021 | $150,000 | -3.2% | 3,260 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $155,000 | +10.7% | 3,268 | -0.5% | 0.00% | 0.0% |
| Q3 2020 | $140,000 | +32.1% | 3,286 | +26.9% | 0.00% | 0.0% |
| Q2 2020 | $106,000 | +43.2% | 2,590 | +26.0% | 0.00% | 0.0% |
| Q1 2020 | $74,000 | – | 2,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nova R Wealth, Inc. | 455,058 | $19,048,715 | 12.88% |
| Alterity Financial Group, LLC | 12,286 | $514,309 | 0.75% |
| Cornerstone Advisory, LLC | 85,260 | $3,568,968 | 0.64% |
| Owen LaRue, LLC | 12,912 | $557,156 | 0.60% |
| Semus Wealth Partners LLC | 13,170 | $551,296 | 0.59% |
| PRIMORIS WEALTH ADVISORS, LLC | 7,984 | $334,194 | 0.41% |
| CORRADO ADVISORS, LLC | 9,285 | $388,671 | 0.26% |
| Founders Financial Alliance, LLC | 10,612 | $444,336 | 0.22% |
| Diversified, LLC | 12,870 | $538,733 | 0.19% |
| Waterfront Wealth Inc. | 7,744 | $324,178 | 0.11% |